2020 ePoster – GN – Acute kidney injury

L SKEAT1,2, S YEW1, G GENEVIEVE2 1Royal Hobart Hospital, Hobart, Australia, 2University of Tasmania, Hobart, Australia Background: The authors present a case of a 13-year-old boy with acute renal failure from ingestion of the toxic mushroom Cortinarius eartoxicus, a species...
E PAN1, J CHUA1 1Peninsula Health, Frankston, Australia Background: Atypical haemolytic uraemic syndrome (aHUS) is a rare condition that presents with a triad of microangiopathic haemolytic anaemia, thrombocytopenia and acute kidney injury. Diagnosis can be difficult due to other conditions...
P NAIDU1, J PATERSON1 1Austin Health, Heidelberg, Australia Background: Hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly known as statins, are well recognised in the management of hyperlipidaemia with established cardiovascular benefits. The adverse effect of rhabdomyolysis, in which there is...
A KRELLE1, V KALAPURACKAL MATHAI1, G KIRKLAND1, L NOTT1, M JOSE2 1The Royal Hobart Hospital, Hobart, Australia, 2The University of Tasmania, Hobart, Australia Background: Treatment with the combination of molecular targeted therapy, dabrafenib (BRAF inhibitor) plus trametinib (MEK1/MEK2 inhibitor) has...
J HA1,2, M FRENCH1, E CHUNG1, K TANG1, M FERNANDO1 1The Prince Of Wales Hospital, Sydney, Australia, 2The George Institute for Global Health, UNSW Sydney, Sydney, Australia Background: A 78-year-old man with biopsy-proven oxalate nephropathy secondary to enteric hyperoxaluria post-Whipple’s...
T GOREGUES1,2, S GOVINDARAJULU1 1Toowoomba Hospital Nephrology Service, Toowoomba, Australia, 2Griffith University, Southport, Australia Background: Differentiating between atypical haemolytic uraemic syndrome (aHUS) and other thrombotic microangiopathies (TMA) can be clinically challenging. In all forms of TMA, the abdominal symptoms due...
J CHUA1, K WONG1, V VENKATARAMAN1 1Peninsula Health, Frankston, Australia Background: Acute interstitial nephritis is a well-recognised adverse effect of checkpoint inhibitor immunotherapy, which is increasingly used in a range of oncological conditions. We present a case of a patient...
K WT CHAU1, N DULLAGHAN1, S BHUTIA2 1Department of Medicine, Cairns Hospital, Cairns, Australia, 2Cairns Vascular Unit, Cairns Hospital, Cairns, Australia Aim: To determine the incidence of Acute Kidney Injury (AKI) and its contributing risk factors, in patients receiving endovascular...
A BENDALL1, S KUO1, M ALYOUSEF3, M FINLAY3, K MASON2, K NICHOLLS1,4 1Department of Nephrology, Royal Melbourne Hospital, Melbourne , Australia , 2Department of Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne , Australia , 3Department...
P BALI1, L HIDAYATI1, C NELSON1, C DOW1,2,3 1Western Health, Footscray, Australia, 2Dorevitch pathology at Western Health, 3Department of Medicine, University of Melbourne Background: Thrombopoietin- receptor agonists increase platelet count by stimulating megakaryocytes. Eltrombopag is reserved for patients with idiopathic...
Recent Comments
    Categories